Host: Caitlin Costello, MD Guest: Ravi Vij, MD Frontline management of patients with newly diagnosed multiple myeloma is complicated by a multitude of current and newer agents, and navigating the guidelines can be confusing. Tune in as Drs. Caitlin

Host: Septimiu Murgu, MD, FCCP Host: Eric Edell, MD, FCCP Guest: Narjust Duma, MD Guest: Andreas Rimner, MD Two internationally known medical and radiation oncologists will discuss ongoing and recent clinical trials and offer their perspectives

Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Andrea S. Lukes, MD, MHSc, FACOG By 50 years of age, 70% to 80% of women are affected by uterine fibroids, and nearly 10% of women are affected by endometriosis. Clinical trial data demonstrate that GnR

Host: Peter Libby, MD Guest: Lawrence A. Leiter, MD Guest: Prof. Kausik Ray, MBChB, MD, MPhil This CME Roundtable highlights key takeaways and late-breaking data shared at a symposium held at the AHA annual meeting. Hear updated management strate

Host: Adam M. Brufsky, MD, PhD Host: Nina Thomas, MD Interstitial lung disease (ILD) is a heterogeneous group of diseases that produce inflammation and fibrosis of the parenchyma, affecting the alveolar, interstitial, and vascular spaces. Drug-indu

Host: Clete A. Kushida, MD, PhD Guest: Lois E. Krahn, MD Tune in to hear about new treatments for patients with narcolepsy. Data were recently presented at the American College of Chest Physicians Annual Meeting, and Drs. Clete Kushida and Lois Kra

Host: Daniel P. Petrylak, MD Guest: Arlene O. Siefker-Radtke, MD It's critical that we select and sequence appropriate therapeutics to provide our patients with the best possible outcomes. Dr. Petrylak and Dr. Siefker-Radtke provide a rundown of mu

Host: Mark Socinski, MD Guest: Justin Gainor With an expanding arena of available selective RET inhibitors and more data being released on emerging therapies, the landscape for patients with RET-positive metastatic NSCLC is evolving rapidly. Join D

Host: Peter Rossing, DMSc, MD Guest: Gerasimos Filippatos, MD, FESC, FHFA Guest: Matthew R. Weir, MD Achieving optimal outcomes in the treatment of patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) remains a challenge, and trea

Host: Ileana L. Piña, MD, MPH, FAHA, FACC Guest: Javed Butler, MD, MBA, MPH Guest: Marco Metra, MD Guest: Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA In the management of patients with heart failure, foundational therapy is critical to improving